Trial Profile
Clinical Trials Insight: 700030991
Status:
Planning
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 29 Feb 2008
Price :
$35
*
At a glance
- Drugs Triciribine (Primary) ; Erlotinib
- Indications Solid tumours
- Focus Therapeutic Use
- 29 Feb 2008 New trial record.